Desmopressin Acetate Tablets — Class II drug recall D-0830-2020
Terminated recall by Teva Pharmaceuticals USA, reported 2020-02-12, distributed nationwide. GMP Deviations: Product bottle may be absent of desiccant.
| Recall number | D-0830-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Parsippany, NJ, United States |
| Recall initiated | 2020-01-27 |
| Classified | 2020-02-06 |
| Reported by FDA | 2020-02-12 |
| Terminated | 2020-12-10 |
| Distributed | Nationwide (US) |
| Quantity | 22,868 bottles |
| Reason classes | cgmp |
| NDC | 00591-2464-01 |
| Lot numbers | 1281203M, 1290113M |
| Expiration dates | 2020-03, 2020-04 |
Product
Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01
Reason for recall
GMP Deviations: Product bottle may be absent of desiccant.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0830-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.